Focal adhesion kinase regulates intestinal epithelial barrier function via redistribution of tight junction

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 1, 2013, Pages 151-159

  Ma, Yanju ^a,b   Semba, Shingo ^a   Khan, Md Rafiqul Islam ^a   Bochimoto, Hiroki ^a   Watanabe, Tsuyoshi ^a   Fujiya, Mikihiro ^a   Kohgo, Yutaka ^a   Liu, Yunpeng ^b   Taniguchi, Takanobu ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial barrier; Focal adhesion kinase; Occludin; Tight junction; ZO 1

Indexed keywords

ALCOHOL; CELL PROTEIN; CLAUDIN 1; FOCAL ADHESION KINASE; FOCAL ADHESION KINASE INHIBITOR; PF 228; PF 573; SMALL INTERFERING RNA; TJ PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; CELL DISRUPTION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL REGENERATION; CELL STRAIN CACO 2; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTESTINE EPITHELIUM; PRIORITY JOURNAL; SUCROSE GRADIENT ULTRACENTRIFUGATION; TIGHT JUNCTION;

AMINO ACID MOTIFS; CACO-2 CELLS; EPITHELIAL CELLS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTESTINES; PHOSPHORYLATION; TIGHT JUNCTIONS;

EID: 84868538987     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.10.006     Document Type: Article

References (40)

1. Ma T.Y., Anderson J.M. Tight junctions and the intestinal barrier. Physiology of the Gastrointestinal Tract 2006, 1559-1594. Elsevier, Burlington, MA.
2. Turner J.R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 2009, 9:799-809.
3. Zhong W., Zhao Y., McClain C.J., Kang Y.J., Zhou Z. Inactivation of hepatocyte nuclear factor-4{alpha} mediates alcohol-induced downregulation of intestinal tight junction proteins. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G643-G651.
4. Mankertz J., Schulzke J.D. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr. Opin. Gastroenterol. 2007, 23:379-383.
5. Farquhar M., Palade G. Junctional complexes in various epithelia. J. Cell Biol. 1963, 17:375-412.
6. Cereijido M., Contreras R.G., Shoshani L., Flores-Benitez D., Larre I. Tight junction and polarity interaction in the transporting epithelial phenotype. Biochim. Biophys. Acta 2008, 1778:770-793.
7. Balda M.S., Matter K. Tight junctions at a glance. J. Cell Sci. 2008, 121:3677-3682.
8. Turner J.R. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am. J. Pathol. 2006, 169:1901-1909.
9. Utech M., Brüwer M., Nusrat A. Tight junctions and cell-cell interactions. Methods Mol. Biol. 2006, 341:185-195.
10. Watson C.J., Hoare C.J., Garrod D.R., Carlson G.L., Warhurst G. Interferon-gamma selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores. J. Cell Sci. 2005, 118:5221-5230.
11. Wang F., Graham W.V., Wang Y., Witkowski E.D., Schwarz B.T., Turner J.R. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am. J. Pathol. 2005, 166:409-419.
12. Zhao X., Peng X., Sun S., Park A.Y., Guan J.L. Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic development. J. Cell Biol. 2010, 189:955-965.
13. Holinstat M., Knezevic N., Broman M., Samarel A.M., Malik A.B., Mehta D. Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeability. J. Biol. Chem. 2006, 281:2296-2305.
14. Quadri S.K., Bhattacharjee M., Parthasarathi K., Tanita T., Bhattacharya J. Endothelial barrier strengthening by activation of focal adhesion kinase. J. Biol. Chem. 2003, 278:13342-13349.
15. Siu E.R., Wong E.W., Mruk D.D., Porto C.S., Cheng C.Y. Focal adhesion kinase is a blood-testis barrier regulator. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9298-9303.
16. Siu E.R., Wong E.W., Mruk D.D., Sze K.L., Porto C.S., Cheng C.Y. An occludin-focal adhesion kinase protein complex at the blood-testis barrier: a study using the cadmium model. Endocrinology 2009, 150:3336-3344.
17. Golubovskaya V., Kaur A., Cance W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. Biochim. Biophys. Acta 2004, 1678:111-125.
18. Walsh M.F., Ampasala D.R., Hatfield J., Vander Heide R., Suer S., Rishi A.K., Basson M.D. Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms. Am. J. Pathol. 2008, 173:385-399.
19. Ma Y., Semba S., Maemoto A., Takeuchi M., Kameshita I., Ishida A., Kato S., Katoh T., Liu Y., Taniguchi T. Oxazolone-induced over-expression of focal adhesion kinase in colonic epithelial cells of colitis mouse model. FEBS Lett. 2010, 584:3949-3954.
20. Slack-Davis J.K., Martin K.H., Tilghman R.W., Iwanicki M., Ung E.J., Autry C., Luzzio M.J., Cooper B., Kath J.C., Roberts W.G., Parsons J.T. Cellular characterization of a novel focal adhesion kinase inhibitor. J. Biol. Chem. 2007, 282:14845-14852.
21. Jones M.L., Shawe-Taylor A.J., Williams C.M., Poole A.W. Characterization of a novel focal adhesion kinase inhibitor in human platelets. Biochem. Biophys. Res. Commun. 2009, 389:198-203.
22. Tomar A., Lim S.-T., Lim Y., Schlaepfer D.D. A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells. J. Cell Sci. 2009, 122:1852-1862.
23. Ma T.Y., Nguyen D., Bui V., Nguyen H., Hoa N. Ethanol modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. 1999, 276:G965-G974.
24. Skalski M., Sharma N., Williams K., Kruspe A., Coppolino M.G. SNARE-mediated membrane traffic is required for focal adhesion kinase signaling and Src-regulated focal adhesion turnover. Biochim. Biophys. Acta 2011, 1813:148-158.
25. Harhaj N.S., Barber A.J., Antonetti D.A. Platelet-derived growth factor mediates tight junction redistribution and increases permeability in MDCK cells. J. Cell. Physiol. 2002, 193:349-364.
26. Clayburgh D.R., Rosen S., Witkowski E.D., Wang F., Blair S., Dudek S., Garcia J.G., Alverdy J.C., Turner J.R. A differentiation-dependent splice variant of myosin light chain kinase, MLCK1, regulates epithelial tight junction permeability. J. Biol. Chem. 2004, 279:55506-55513.
27. Madara J.L., Dharmsathaphorn K. Occluding junction structure-function relationships in a cultured epithelial monolayer. J. Cell Biol. 1985, 101:2124-2133.
28. Franchini K.G. Focal adhesion kinase - the basis of local hypertrophic signaling domains. J. Mol. Cell. Cardiol. 2012, 52:485-492.
29. Basuroy S., Sheth P., Kuppuswamy D., Balasubramanian S., Ray R.M., Rao R.K. Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J. Biol. Chem. 2003, 278:11916-11924.
30. Kale G., Naren A.P., Sheth P., Rao R.K. Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3. Biochem. Biophys. Res. Commun. 2003, 302:324-329.
31. Elias B.C., Suzuki T., Seth A., Giorgianni F., Kale G., Shen L., Turner J.R., Naren A., Desiderio D.M., Rao R. Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions. J. Biol. Chem. 2009, 284:1559-1569.
32. Takenaga Y., Takagi N., Murotomi K., Tanonaka K., Takeo S. Inhibition of Src activity decreases tyrosine phosphorylation of occludin in brain capillaries and attenuates increase in permeability of the blood-brain barrier after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2009, 29:1099-1108.
33. Yan H.H., Mruk D.D., Lee W.M., Cheng C.Y. Blood-testis barrier dynamics are regulated by testosterone and cytokines via their differential effects on the kinetics of protein endocytosis and recycling in Sertoli cells. FASEB J. 2008, 22:1945-1959.
34. Lee D.B.N., Huang E., Ward H.J. Tight junction biology and kidney dysfunction. Am. J. Physiol. 2006, 290:F20-F34.
35. Mankertz J., Tavalali S., Schmitz H., Mankertz A., Riecken E.O., Fromm M., Schulzke J.D. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J. Cell Sci. 2000, 113(Pt 11):2085-2090.
36. Amasheh M., Fromm A., Krug S.M., Amasheh S., Andres S., Zeitz M., Fromm M., Schulzke J.-D. TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling. J. Cell Sci. 2010, 123:4145-4155.
37. Frame M.C., Patel H., Serrels B., Lietha D., Eck M.J. The FERM domain: organizing the structure and function of FAK. Nat. Rev. Mol. Cell Biol. 2010, 11:802-814.
38. Golubovskaya V.M., Figel S., Ho B.T., Johnson C.P., Yemma M., Huang G., Zheng M., Nyberg C., Magis A., Ostrov D.A., Gelman I.H., Cance W.G. A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo. Carcinogenesis 2012, 33:1004-1013.
39. Golubovskaya V.M. Focal adhesion kinase as a cancer therapy target. Anticancer Agents Med. Chem. 2010, 10:735-741.
40. McLean G.W., Avizienyte E., Frame M.C. Focal adhesion kinase as a potential target in oncology. Expert. Opin. Pharmacother. 2003, 4:227-234.